By Robyn G Knapp August 8, 2025 - 3:05am

For advanced research into combination therapies, CAG-SEMA 5/5mg represents an innovative compound blend now offered by purapeptides. This dual-action peptide is supplied in research-grade format for scientists exploring novel treatment models and metabolic functions. Purapeptides packages CAG-SEMA with detailed product data and ensures that it is intended strictly for non-human, controlled laboratory research.